Hematein

Hematein is an inhibitor of CK2 used in studies of kinase signaling. It is especially relevant in cancer, cell signaling, and metabolism models, where defined compound exposure can be linked to phosphorylation signaling, target engagement, and selectivity relationships.

By inhibiting CK2, Hematein can be used to examine phosphorylation signaling, target engagement, and selectivity relationships. This target class is commonly examined through biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping. In cancer, cell signaling, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving CK2
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
• Phenotypic profiling in cancer, cell signaling, and metabolism models

Overall, Hematein is appropriate when a defined chemical perturbant is needed to connect CK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.